scispace - formally typeset
M

Madelon C. Vonk

Researcher at Radboud University Nijmegen

Publications -  186
Citations -  12804

Madelon C. Vonk is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Pulmonary hypertension & Internal medicine. The author has an hindex of 41, co-authored 170 publications receiving 10336 citations. Previous affiliations of Madelon C. Vonk include Radboud University Nijmegen Medical Centre & VU University Amsterdam.

Papers
More filters
Journal ArticleDOI

2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

Frank H J van den Hoogen, +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

Frank H J van den Hoogen, +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A Tyndall, +46 more
TL;DR: Disease-related causes, in particular pulmonary fibrosis, PAH and cardiac causes, accounted for the majority of deaths in SSc.
Journal ArticleDOI

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial

TL;DR: Among patients with early diffuse cutaneous systemic sclerosis, HSCT was associated with increased treatment-related mortality in the first year after treatment, however, HCST conferred a significant long-term event-free survival benefit.